LA JOLLA—Physician, inventor, and venture capitalist Andrew “Drew” Senyei, MD, has been newly appointed to the Salk Institute’s Board of Trustees. He will work alongside business and nonprofit leaders from around the world to advance Salk’s foundational and innovative biology research.
Click here for a high-resolution image.
Senyei has worked in the healthcare and emerging technology industries for over 30 years and is credited with more than 30 patents and 45 peer-reviewed publications. He has also served on the boards of more than 30 private and public companies.
“Drew understands the value of early-stage science and has been critical to the development of numerous cutting-edge medical technologies,” says Salk President Gerald Joyce, MD, PhD. “His wealth of experience advising scientific institutions will be a great resource to us, and we…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
